| abstract |
The present invention relates to a hydrated crystalline form of 6-hydroxy-3- (4- [2- (piperidin-1-yl) ethoxy] phenoxy) -2- (4-methoxyphenyl) benzo [b] thiophene hydrochloride and uses of, including inhibition of estrogen-related disease-related conditions including cardiovascular disease, hyperlipidemia and osteoporosis, and inhibition of other pathological conditions such as endometriosis, uterine fibrosis, breast and m tras), prostate cancer, benign prostatic hyperplasia, CNS disorders including Alzeimer's disease, prevention of breast cancer, and upregulation of ChAT.y |